| Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance Y Stern, EM Arenaza‐Urquijo, D Bartrés‐Faz, S Belleville, M Cantilon, ... Alzheimer's & Dementia 16 (9), 1305-1311, 2020 | 1101 | 2020 |
| Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ... Annals of neurology 74 (6), 905-913, 2013 | 248 | 2013 |
| Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ... Brain 140 (8), 2112-2119, 2017 | 241 | 2017 |
| Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease YY Lim, P Maruff, RH Pietrzak, D Ames, KA Ellis, K Harrington, ... Brain 137 (1), 221-231, 2014 | 234 | 2014 |
| Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study RH Pietrzak, YY Lim, A Neumeister, D Ames, KA Ellis, K Harrington, ... JAMA psychiatry 72 (3), 284-291, 2015 | 223 | 2015 |
| Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts RF Buckley, EC Mormino, RE Amariglio, MJ Properzi, JS Rabin, YY Lim, ... Alzheimer's & Dementia 14 (9), 1193-1203, 2018 | 195 | 2018 |
| Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer’s disease P Maruff, YY Lim, D Darby, KA Ellis, RH Pietrzak, PJ Snyder, AI Bush, ... BMC psychology 1, 1-11, 2013 | 192 | 2013 |
| Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a meta-analysis JE Baker, YY Lim, RH Pietrzak, J Hassenstab, PJ Snyder, CL Masters, ... Alzheimer's & dementia: Diagnosis, assessment & disease monitoring 6, 108-121, 2017 | 190 | 2017 |
| Combined neuropathological pathways account for age‐related risk of dementia MC Power, E Mormino, A Soldan, BD James, L Yu, NM Armstrong, ... Annals of neurology 84 (1), 10-22, 2018 | 154 | 2018 |
| Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study YY Lim, KA Ellis, K Harrington, D Ames, RN Martins, CL Masters, C Rowe, ... Journal of clinical and experimental neuropsychology 34 (4), 345-358, 2012 | 154 | 2012 |
| Dietary patterns and cognitive decline in an Australian study of ageing SL Gardener, SR Rainey-Smith, MB Barnes, HR Sohrabi, M Weinborn, ... Molecular psychiatry 20 (7), 860-866, 2015 | 153 | 2015 |
| APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease YY Lim, VL Villemagne, SM Laws, RH Pietrzak, PJ Snyder, D Ames, ... Molecular psychiatry 20 (11), 1322-1328, 2015 | 142 | 2015 |
| BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ... Neurobiology of aging 34 (11), 2457-2464, 2013 | 142 | 2013 |
| Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults YY Lim, KA Ellis, RH Pietrzak, D Ames, D Darby, K Harrington, RN Martins, ... Neurology 79 (16), 1645-1652, 2012 | 120 | 2012 |
| Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers … YY Lim, J Jaeger, K Harrington, T Ashwood, KA Ellis, A Stöffler, C Szoeke, ... Archives of clinical neuropsychology 28 (4), 320-330, 2013 | 112 | 2013 |
| Nonvascular retinal imaging markers of preclinical Alzheimer's disease PJ Snyder, LN Johnson, YY Lim, CY Santos, J Alber, P Maruff, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 4, 169-178, 2016 | 107 | 2016 |
| APOE genotype and early β-amyloid accumulation in older adults without dementia YY Lim, EC Mormino, Alzheimer's Disease Neuroimaging Initiative, ... Neurology 89 (10), 1028-1034, 2017 | 105 | 2017 |
| Determining clinically meaningful decline in preclinical Alzheimer disease PS Insel, M Weiner, RS Mackin, E Mormino, YY Lim, E Stomrud, ... Neurology 93 (4), e322-e333, 2019 | 104 | 2019 |
| Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented … YY Lim, PJ Snyder, RH Pietrzak, A Ukiqi, VL Villemagne, D Ames, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 2, 19-26, 2016 | 102 | 2016 |
| Effect of BDNF Val66Met on memory decline and hippocampal atrophy in prodromal Alzheimer’s disease: a preliminary study YY Lim, VL Villemagne, SM Laws, D Ames, RH Pietrzak, KA Ellis, ... PloS one 9 (1), e86498, 2014 | 100 | 2014 |
Paul MaruffProfessor, Florey Institute for Neuroscience and Mental Health在 unimelb.edu.au 的电子邮件经过验证
